Julia Sidenius Johansen

Julia Sidenius Johansen

Clinical Professor

Member of:

  • Clinical Oncology


  1. 1991
  2. Published

    The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones

    Hassager, Christian, Jensen, Lars Thorbjørn, Johansen, Julia Sidenius, Riis, B. J., Melkko, J., Pødenphant, J., Risteli, L., Christiansen, C. & Risteli, J., Feb 1991, In: Metabolism. 40, 2, p. 205-8 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 1992
  4. Published

    Serum bone γ-carboxyglutamic acid protein in a longitudinal study of infants: Lower values in formula-fed infants

    Michaelsen, Kim F., Johansen, Julia Sidenius, Samuelson, G., Price, P. A. & Christiansen, C., 1992, In: Pediatric Research. 31, 4, p. 401-405 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Types I and III procollagen extension peptides in serum respond to fracture in humans

    Jørring, Stig, Jensen, Lars Thorbjørn, Andersen, G. R. & Johansen, Julia Sidenius, 1992, In: Archives of Orthopaedic and Trauma Surgery. 111, 5, p. 265-7 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 1998
  7. Published

    YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils

    Volck, B., Price, P. A., Johansen, Julia Sidenius, Sørensen, O., Benfield, T., Nielsen, H. J., Calafat, J. & Borregaard, N., 1998, In: Proceedings of the Association of American Physicians. 110, 4, p. 351-360 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 1999
  9. Published

    Serum YKL-40 and colorectal cancer

    Cintin, C., Johansen, J. S., Christensen, I. J., Price, P. A., Sørensen, S., Nielsen, H. J., Schulze, S., Thorup, J., Wille-Jøegensen, P., Bentzen, E., Christoffersen, I., Møller, P., Banke, L., Froberg, D., Henriksen, F. W., Crone, P., Hesselfeldt, P., Sparsø, B. H., Larsen, K. L., Asmussen, T. & 28 others, Heiner, J., Hansen, Ole, Flyger, H., Jess, P., Iversen, J., La Cour-Andersen, J., Vennits, B., Moesgraad, F., Hammer, J., Fischer, A., Galatius, H., Naver, L., Teilum, D., Holbraad, L., Iversen, O., Nymark, J., Roikjær, Ole, Svendsen, Lars Bo, Vedel, L., Palm, L., Rasmussen, K. C., Friis, J., Lanng, C., Wiboltt, K., Jensen, N. C., Hoffman, N., Larsen, T. & Packler, J., 1999, In: British Journal of Cancer.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. 2005
  11. Published

    Circulating YKL-40 levels during human endotoxaemia

    Johansen, Julia Sidenius, Krabbe, K. S., Møller, Kirsten & Pedersen, Bente Klarlund, 2005, In: Clinical and Experimental Immunology. 140, 343-348

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?

    Johansen, Julia Sidenius, Milman, N., Hansen, M., Garbarsch, C., Price, P. A. & Graudal, N., 1 Apr 2005, In: Respiratory Medicine. 99, 4, p. 396-402 7 p.

    Research output: Contribution to journalJournal articleResearch

  13. 2006
  14. Published

    Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

    Schmidt, H., Johansen, Julia Sidenius, Gehl, Julie, Geertsen, P. F., Fode, K. & von der Maase, H., 2006, In: Cancer. 106, 5, p. 1130-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma

    Schmidt, H., Johansen, Julia Sidenius, Sjoegren, P., Christensen, I. J., Sorensen, B. S., Fode, K., Larsen, J. & von der Maase, H., 2006, In: Journal of Clinical Oncology. 24, 5, p. 798-804 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

    Rathcke, C. N., Johansen, Julia Sidenius & Vestergaard, H., Feb 2006, In: Inflammation Research. 55, 2, p. 53-9 7 p.

    Research output: Contribution to journalJournal articleResearch

Previous 1 2 3 4 5 6 7 8 ...22 Next

ID: 13762833